• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎和溃疡性结肠炎患者不同的肠道微生物群特征。

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.

作者信息

Bajer Lukas, Kverka Miloslav, Kostovcik Martin, Macinga Peter, Dvorak Jiri, Stehlikova Zuzana, Brezina Jan, Wohl Pavel, Spicak Julius, Drastich Pavel

机构信息

Lukas Bajer, Peter Macinga, Jan Brezina, Pavel Wohl, Julius Spicak, Pavel Drastich, Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic.

出版信息

World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.

DOI:10.3748/wjg.v23.i25.4548
PMID:28740343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5504370/
Abstract

AIM

To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC).

METHODS

Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with ( = 32) or without ( = 11) concomitant inflammatory bowel disease, 32 UC patients, and 31 healthy controls. The V3 and V4 regions of the 16S ribosomal RNA gene were sequenced on Illumina MiSeq platform to cover low taxonomic levels. Data were further processed in QIIME employing MaAsLin and LEfSe tools for analysis of the output data.

RESULTS

Microbial profiles in both PSC and UC were characterized by low bacterial diversity and significant change in global microbial composition. , , , , and three other genera were markedly overrepresented in PSC regardless of concomitant inflammatory bowel disease (IBD). , and were tracked to the species level to identify , , , and along with and . PSC was further characterized by decreased abundance of and . Decrease in genus was linked to presence of colonic inflammation regardless of IBD phenotype. , and were decreased in UC along with genus . Low levels of serum albumin were significantly correlated with enrichment of order Actinomycetales.

CONCLUSION

PSC is associated with specific gut microbes independently of concomitant IBD and several bacterial taxa clearly distinguish IBD phenotypes (PSC-IBD and UC).

摘要

目的

对原发性硬化性胆管炎(PSC)和溃疡性结肠炎(UC)患者的肠道细菌微生物群进行特征分析。

方法

收集了106名研究参与者的粪便样本并获取了相关临床数据,其中包括43例PSC患者,其中32例伴有炎性肠病,11例不伴有炎性肠病,32例UC患者以及31名健康对照者。在Illumina MiSeq平台上对16S核糖体RNA基因的V3和V4区域进行测序,以涵盖低分类水平。数据在QIIME中进一步处理,采用MaAsLin和LEfSe工具对输出数据进行分析。

结果

PSC和UC中的微生物谱均以细菌多样性低和整体微生物组成的显著变化为特征。无论是否伴有炎性肠病(IBD),在PSC中,[具体菌属1]、[具体菌属2]、[具体菌属3]、[具体菌属4]、[具体菌属5]和其他三个菌属的含量均明显过高。[具体菌属1]、[具体菌属2]和[具体菌属3]追踪到种水平,分别鉴定为[具体菌种1]、[具体菌种2]、[具体菌种3]、[具体菌种4]以及[具体菌种5]和[具体菌种6]。PSC的进一步特征是[具体菌属6]和[具体菌属7]的丰度降低。无论IBD表型如何,[具体菌属8]的减少与结肠炎症的存在有关。在UC中,[具体菌属9]、[具体菌属10]和[具体菌属11]以及[具体菌属8]均减少。血清白蛋白水平低与放线菌目丰度增加显著相关。

结论

PSC与特定的肠道微生物有关,独立于伴随的IBD,并且几种细菌分类群可明确区分IBD表型(PSC-IBD和UC)。

相似文献

1
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.原发性硬化性胆管炎和溃疡性结肠炎患者不同的肠道微生物群特征。
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.
2
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.原发性硬化性胆管炎患者的肠道微生物谱与无胆道疾病的溃疡性结肠炎患者和健康对照者不同。
Gut. 2017 Apr;66(4):611-619. doi: 10.1136/gutjnl-2015-310500. Epub 2016 Feb 17.
3
Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.意大利儿科原发性硬化性胆管炎和溃疡性结肠炎患者的肠道微生物群和真菌群特征。
Inflamm Bowel Dis. 2024 Apr 3;30(4):529-537. doi: 10.1093/ibd/izad203.
4
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.原发性硬化性胆管炎的特征是存在独立于炎症性肠病的肠道菌群失调。
Gut. 2016 Oct;65(10):1681-9. doi: 10.1136/gutjnl-2015-311004. Epub 2016 May 20.
5
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.伴有和不伴有原发性硬化性胆管炎的溃疡性结肠炎患者肠道微生物群的特征分析
J Crohns Colitis. 2016 Mar;10(3):330-7. doi: 10.1093/ecco-jcc/jjv204. Epub 2015 Nov 2.
6
Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.肠道微生物群有助于溃疡性结肠炎两种中医证候的区分。
World J Gastroenterol. 2019 Jul 7;25(25):3242-3255. doi: 10.3748/wjg.v25.i25.3242.
7
A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.原发性硬化性胆管炎-炎症性肠病的结肠基因表达、肠道微生物群和免疫浸润的综合分析:疾病与胆汁酸途径的关联。
J Crohns Colitis. 2020 Jul 30;14(7):935-947. doi: 10.1093/ecco-jcc/jjaa021.
8
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
9
Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.原发性硬化性胆管炎合并溃疡性结肠炎患儿和青少年的肠道微生物组。
Front Immunol. 2021 Feb 5;11:598152. doi: 10.3389/fimmu.2020.598152. eCollection 2020.
10
The features of mucosa-associated microbiota in primary sclerosing cholangitis.原发性硬化性胆管炎中黏膜相关微生物群的特征。
Aliment Pharmacol Ther. 2016 Apr;43(7):790-801. doi: 10.1111/apt.13552. Epub 2016 Feb 9.

引用本文的文献

1
Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation.低聚半乳糖通过调节微生物群促进肠道屏障完整性并对葡聚糖硫酸钠诱导的结肠炎发挥抗炎作用。
Int J Mol Sci. 2025 Aug 18;26(16):7968. doi: 10.3390/ijms26167968.
2
Oral, not gut microbiota diversity, reflects the inflammation and neoplasia in patients with uveitis and vitreoretinal lymphoma.口腔微生物群的多样性而非肠道微生物群的多样性反映了葡萄膜炎和玻璃体视网膜淋巴瘤患者的炎症和肿瘤形成情况。
J Ophthalmic Inflamm Infect. 2025 Aug 21;15(1):63. doi: 10.1186/s12348-025-00517-2.
3
Serological Markers of Intestinal Barrier Function and Inflammation as Potential Predictors of Recurrent Primary Sclerosing Cholangitis.

本文引用的文献

1
Intestinal Microbiota: Facts and Fiction.肠道微生物群:事实与虚构
Dig Dis. 2017;35(1-2):139-147. doi: 10.1159/000449095. Epub 2017 Feb 1.
2
Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann .鲁勒曼对《粪便微生物群谱作为原发性硬化性胆管炎的诊断生物标志物》的回应
Gut. 2017 Apr;66(4):755-756. doi: 10.1136/gutjnl-2016-312347. Epub 2016 Jun 23.
3
Ultrasound and Point Shear Wave Elastography in Livers of Patients with Primary Sclerosing Cholangitis.原发性硬化性胆管炎患者肝脏的超声及点剪切波弹性成像
肠道屏障功能和炎症的血清学标志物作为复发性原发性硬化性胆管炎的潜在预测指标
Clin Exp Gastroenterol. 2025 Jul 19;18:171-178. doi: 10.2147/CEG.S508794. eCollection 2025.
4
Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review.在拉替拉韦、多替拉韦和比克替拉韦背景下绘制肠道微生物群组成的范围综述
Int J Mol Sci. 2025 Jul 2;26(13):6366. doi: 10.3390/ijms26136366.
5
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study.精神病理学和肠道微生物群对溃疡性结肠炎疾病进展的影响:一项五年随访研究
Microorganisms. 2025 May 25;13(6):1208. doi: 10.3390/microorganisms13061208.
6
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases.肠道微生物群对肝脏和肠道疾病中肠道通透性的影响。
Microorganisms. 2025 May 23;13(6):1188. doi: 10.3390/microorganisms13061188.
7
Oral microbiota and biliary tract cancers: unveiling hidden mechanistic links.口腔微生物群与胆道癌:揭示隐藏的机制联系
Front Oncol. 2025 Jun 11;15:1585923. doi: 10.3389/fonc.2025.1585923. eCollection 2025.
8
Anti-inflammatory effects and gut microbiota modulation of synbiotic mulberry in DSS-induced colitis rats.合生元桑椹对葡聚糖硫酸钠诱导的结肠炎大鼠的抗炎作用及肠道微生物群调节作用
Mol Cell Biochem. 2025 May 21. doi: 10.1007/s11010-025-05309-9.
9
The intestinal mucosa-associated microbiota in IBD-associated arthritis displays lower relative abundance of .炎症性肠病相关关节炎中肠道黏膜相关微生物群的相对丰度较低。 (注:原英文文本不完整,“of”后面缺少具体内容)
Gut Microbes. 2025 Dec;17(1):2505114. doi: 10.1080/19490976.2025.2505114. Epub 2025 May 18.
10
Gut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD).肠道微生物群是炎症性肠病(IBD)中一个关键的独立生物标志物。
Int J Mol Sci. 2025 Mar 11;26(6):2503. doi: 10.3390/ijms26062503.
Ultrasound Med Biol. 2016 Sep;42(9):2146-55. doi: 10.1016/j.ultrasmedbio.2016.04.016. Epub 2016 Jun 2.
4
Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.粪便微生物群谱作为原发性硬化性胆管炎的诊断生物标志物
Gut. 2017 Apr;66(4):753-754. doi: 10.1136/gutjnl-2016-312180. Epub 2016 May 23.
5
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.原发性硬化性胆管炎的特征是存在独立于炎症性肠病的肠道菌群失调。
Gut. 2016 Oct;65(10):1681-9. doi: 10.1136/gutjnl-2015-311004. Epub 2016 May 20.
6
The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.原发性硬化性胆管炎合并炎症性肠病的肠道黏附微生物群与炎症性肠病的不同。
Gut. 2017 Feb;66(2):386-388. doi: 10.1136/gutjnl-2016-311915. Epub 2016 Apr 19.
7
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.原发性硬化性胆管炎患者的肠道微生物谱与无胆道疾病的溃疡性结肠炎患者和健康对照者不同。
Gut. 2017 Apr;66(4):611-619. doi: 10.1136/gutjnl-2015-310500. Epub 2016 Feb 17.
8
Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.与炎症性肠病相关的原发性硬化性胆管炎:一项针对南欧人群的观察性研究,重点关注新的治疗选择。
Eur J Gastroenterol Hepatol. 2016 May;28(5):508-13. doi: 10.1097/MEG.0000000000000596.
9
The features of mucosa-associated microbiota in primary sclerosing cholangitis.原发性硬化性胆管炎中黏膜相关微生物群的特征。
Aliment Pharmacol Ther. 2016 Apr;43(7):790-801. doi: 10.1111/apt.13552. Epub 2016 Feb 9.
10
Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.黏膜屏障耗竭和细菌多样性丧失是儿童溃疡性结肠炎的主要异常表现。
J Crohns Colitis. 2016 Apr;10(4):462-71. doi: 10.1093/ecco-jcc/jjv223. Epub 2015 Dec 9.